Han Lan-Ying, Sun Jing-Xin, Liu Chuang, Ai Bing, Piao Ming-Guan, Zhang Changhao, Quan Ji-Shan, Jin Cheng-Hua
Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Pharmacy, Yanbian University, Yanji, China.
Future Med Chem. 2025 Jan;17(2):157-170. doi: 10.1080/17568919.2024.2444868. Epub 2024 Dec 26.
The purpose of this work was to investigate the antimicrobial activity of pyrazole derivatives (21a - i and 23a - o) synthesized.
MATERIALS & METHODS: The pyrazole derivatives were synthesized, molecular docked and tested for their antimicrobial activity, cytotoxicity, and hemolysis rate.
Most of the target compounds showed high selective inhibitory activity against multi-drug resistance compared with other strains. Of these, compounds 21c (MIC = 0.25 µg/mL) and 23 h (MIC = 0.25 µg/mL) showed the strongest antibacterial activity, which was 4-flods than that of the positive control compound gatifloxacin (MIC = 1 µg/mL). Furthermore, compound 23 h showed no cytotoxicity to human LO2 cells, and did not show hemolysis even at ultra-high concentration.
These results prompted that these compounds are valuable for further development as antimicrobial agents.
本研究旨在探究合成的吡唑衍生物(21a - i和23a - o)的抗菌活性。
合成吡唑衍生物,进行分子对接,并测试其抗菌活性、细胞毒性和溶血率。
与其他菌株相比,大多数目标化合物对多重耐药性表现出高选择性抑制活性。其中,化合物21c(MIC = 0.25µg/mL)和23h(MIC = 0.25µg/mL)表现出最强的抗菌活性,是阳性对照化合物加替沙星(MIC = 1µg/mL)的4倍。此外,化合物23h对人LO2细胞无细胞毒性,即使在超高浓度下也未表现出溶血现象。
这些结果表明,这些化合物作为抗菌剂具有进一步开发的价值。